Katrina S Pedersen

12PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 24, 2025
Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.

Patrick M Grierson, Crystal Wolf, Rama Suresh

|Mar 03, 2025
Identification of Candidate Alterations Mediating KRASG12C Inhibitor Resistance in Advanced Colorectal and Pancreatic Cancers.

Khalid Jazieh, Jill Tsai, Sheila Solomon

|Oct 06, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.

Patrick M Grierson, Rama Suresh, Benjamin Tan

|Nov 22, 2022
FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study.

Semra Ince, Malak Itani, Lauren E Henke

|Oct 13, 2022
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

|Jun 14, 2022
Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors.

Jonathan W Goldman, Sarina A Piha-Paul, Brendan Curti

Pageof 2

Frequent Collaborators

4 joint publications

Kian-Huat Lim

3 joint publications

Andrea Wang-Gillam

3 joint publications

Rama Suresh

3 joint publications

Amberly Brown